Carmell (NASDAQ:CTCX) & Intelligent Bio Solutions (NASDAQ:INBS) Head-To-Head Survey

Intelligent Bio Solutions (NASDAQ:INBS) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

Profitability

This table compares Intelligent Bio Solutions and Carmell’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-354.86%	-210.36%	-89.33%
Carmell	N/A	-148.47%	-40.47%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Intelligent Bio Solutions and Carmell, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	0	0	0	0	N/A
Carmell	0	0	0	0	N/A

Insider and Institutional Ownership

33.0% of Intelligent Bio Solutions shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 0.3% of Intelligent Bio Solutions shares are held by company insiders. Comparatively, 29.0% of Carmell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

Intelligent Bio Solutions has a beta of 4.68, suggesting that its share price is 368% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500.

Valuation and Earnings

This table compares Intelligent Bio Solutions and Carmell’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$2.83 million	1.55	-$10.63 million	($38.91)	-0.04
Carmell	N/A	N/A	-$15.44 million	N/A	N/A

Intelligent Bio Solutions has higher revenue and earnings than Carmell.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

About Carmell

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.